East Asia Oncology Phase I Trial Conference (EA-OPIC) is intended to foster the collaboration of phase I studies among Asian countries. Key opinion leaders from academia, industry, and regulatory body are invited to cover a wide range of topics on oncology phase I trials, including the demand, the impact, and even the controversy.